Cancer living outside the body, unravelling a cellular mystery and targeting ‘sleeping’ cancer cells: our latest cutting-edge science projects
Our rapid turn-around funding scheme aims to fund high-risk research that we wouldn’t normally fund.
Breast cancer drug approved for use in Scotland, though concerns remain about patients getting the drug across the UK
Scotland is first part of the UK to make a drug routinely available on the NHS that can extend the lives of women with an aggressive form of breast cancer.
A number of cancer clinical trials involving immunotherapy treatments appear to be showing promise, according to new research.
Despite today's headlines, there's no good evidence linking air pollution with breast cancer.
A drug that uses an antibody to target cancer cells shrank tumours in women with triple negative breast cancer that has spread, according to a clinical trial.
As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates.
Combining new ways to measure molecules could lead to the most accurate picture of tumours ever created. We explore the science behind the approach.
Our new report looks at what GPs know about offering tamoxifen and aspirin to lower the risk of, or prevent, certain cancers.
We're announcing the first winners of our most ambitious science funding awarding ever: The Grand Challenge